Press Release LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer Aug 27
Press Release LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update Aug 17